Oxford Biomed.

Oxford Biomedica (OXB)

Company name:Oxford Biomed.
EPIC:OXBTrading Currency:GBX
Market Sector:SSC5ISIN:GB0006648157
Market Segment:SSMMShare Type:DE
WWW Address:http://www.oxfordbiomedica.co.uk/Description:ORD 1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 10.62 uk.advfn.com/p.php?gfx=/gb/down -0.48 [-4.32] 10.66 10.72 11.26 11.98 10.40 23,341,051
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 329.97 3,107.07 0.00 -0.60 - - - 11.98 - 3.80

Oxford Biomedica Key Figures

(at previous day's close)
Market Cap.329.97m
Shares In Issue3,107.07m
Prev. Close11.10
PE Ratio- 
Dividend Yield-%
EPS - basic-0.60p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-0.16p
Return On Equity (ROE)-131.91%
Operating Margin-73.11%
PEG Factor- 
EPS Growth Rate-17.65%
Dividends PS Growth Rate-%
Net Debt28.99m
Gross Gearing77.85%
Quick Assets25.24m
Net Working Capital18.13m
Intangibles / Fixed Assets4.51%
Turnover PS0.89p
Pre-Tax Profit PS-0.65p
Retained Profit PS-0.54p
Cash PS0.49p
Net Cash PS0.19p
Net Tangible Asset Value PS *0.36p
Net Asset Value PS0.41p
Spread0.06 (0.56%) 

Oxford Biomedica Balance Sheet

LSE:OXB:Liabilities+EQLSE:OXB:Assets

Share Price Performance

Sample Period HighLow
1 week11.989.44
4 weeks11.988.80
12 weeks11.988.31
1 year11.983.80

Share Price Chart (5 years)

Oxford Biomedica Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week9.840.787.939.4413.8010.12
4 weeks9.001.6218.008.8014.8510.15
12 weeks8.602.0223.498.316.689.76
26 weeks8.492.1325.097.756.849.32
1 year4.356.27144.143.807.308.16
3 years6.953.6752.813.004.787.77
5 years2.308.32361.741.333.716.81

Oxford Biomedica Key Management Ratios

Oxford Biomedica Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 6.07 
Tobin's Q Ratio (excl. intangibles)6.24 
Dividend Yield-%
Market-to-Book Ratio26.16 
Price-to-Pre-Tax Profit PS-16.25 
Price-to-Retained Profit PS-19.83 
Price-to-Cash Flow PS-64.62 
Price-to-Sales PS11.88 
Price-to-Net Tangible Asset Value PS29.24 
Price-to-Cash PS21.52 
Net Working Capital PS0.58 
Price Pct to Working Capital PS18.21%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Oxford Biomedica Financial Ratios

(Leverage Ratios)
Debt Ratio73.51%
Debt-to-Equity Ratio2.78 
Debt-to-Equity Ratio (excl. Intgbl)3.10 
Debt-to-Equity Market Value0.11 
Net Gearing50.91%
Net Gearing (excl. Intangibles)52.13%
Gross Gearing77.85%
Gross Gearing (excl. Intangibles)79.71%
Gearing Under 1 Year16.36%
Gearing Under 1 Year (excl. Intgbl)16.75%
Assets/Equity4.51 
Cash/Equity121.56 
(Liquidity Ratios)
Net Working Capital to Total Assets31.83%
Current Ratio2.95 
Quick Ratio (Acid Test)2.71 
Liquidity Ratio1.65 
Cash & Equiv/Current Assets55.88%
(Solvency Ratios)
Enterprise Value349.65m
CFO/Sales-0.18 
CFO/Attributable Profit- 
CFO/Assets-0.09 
CFO/Debt-0.12 
Total Debt/Equity Market Value0.13 
Total Debt/Sales1.60 
Total Debt/Pre-Tax Profit-2.18 
Total Debt44.33m
Total Debt/Net Current Assets2.45%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-4.62%
10 yr Compound Earnings Growth-14.58%
Earn drops > 5% in 10yrs8 
Beta (60-Mnth)Beta (36-Mnth)
0.00450.0011

Oxford Biomedica Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-42.64%
Return On Assets (ROA)-30.59%
Net Profit Margin-59.91%
Assets Turnover0.51 
Return On Equity (ROE)-131.91%
Return On Investment (ROI)-38.56%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-59.91%
(Asset Utilisation Multiples)
Shareholders Equity Turnover2.36 
Fixed Assets Turnover1.00 
Current Assets Turnover1.05 
Net Working Capital Turnover 
Inventory Turnover11.32 
(Other Operating Ratios)
Total Assets-to-Sales1.96 
Debtors-to-Sales42.40%
Debt Collection Period154.77Days

Oxford Biomedica Dividends

Sorry No Data Available

Oxford Biomedica Fundamentals

 31 Dec 2013 (GBP)31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)
turnover5.38100.00%13.62100.00%15.91100.00%27.78100.00%m
pre tax profit-12.76-237.45%-10.80-79.29%-16.98-106.74%-20.31-73.11%m
attributable profit-11.10-206.44%-8.66-63.60%-13.02-81.83%-16.64-59.91%m
retained profit-11.10-206.44%-8.66-63.60%-13.02-81.83%-16.64-59.91%m
eps - basic (p)-0.79 -0.43 -0.51 -0.60 
eps - diluted (p)-0.79 -0.43 -0.51 -0.60 
dividends per share- - - - 

Oxford Biomedica Balance Sheet

 31 Dec 2013 (GBP)31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)
LSE:OXB:Liabilities+EQLSE:OXB:AssetsLSE:OXB:Liabilities+EQLSE:OXB:AssetsLSE:OXB:Liabilities+EQLSE:OXB:AssetsLSE:OXB:Liabilities+EQLSE:OXB:Assets
 31 Dec 2013 (GBP)31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)
ASSETS
fixed assets fixed assets4.0729.83%8.9426.46%24.4047.05%27.5148.32%m
intangibles intangibles2.6319.30%2.116.23%1.743.36%1.332.34%m
fixed investments fixed investments--%--%--%0.661.15%m
current assets - other current assets - other--%--%--%--%m
stocks stocks0.684.98%1.414.16%2.715.22%2.203.87%m
debtors debtors4.0929.99%7.1521.16%13.6526.33%9.9017.39%m
cash & securities cash & securities2.1715.90%14.2041.99%9.3618.04%15.3426.93%m
TOTAL13.64100%33.81100%51.85100%56.94100%m
LIABILITIES
creditors - short creditors - short4.2130.89%9.2327.31%13.1725.40%9.3216.36%m
creditors - long creditors - long0.533.90%1.544.54%27.7953.59%35.0161.49%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL4.7534.78%10.7731.85%40.9678.99%44.3377.85%m
EQUITY
ord cap, reserves ord cap, reserves8.9065.22%23.0468.15%10.8921.01%12.6222.15%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL8.9065.22%23.0468.15%10.8921.01%12.6222.15%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Oxford Biomedica Cash Flow Statement

31 Dec 2013 (GBP)31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)
Operating CF-11.02-6.03-13.12-5.11m
Pre-Financing CF-6.79-11.56-29.80-11.52m
Retained CF-6.7912.03-4.845.98m

Oxford Biomedica Brokers

NameActivityTypeMnemonicCode
J.P. Morgan Cazenove LimitedMarket Maker(MME)Broker/DealerCAZRCAZEGB2L
Nomura Code Securities LimitedMarket Maker(MME)Broker/DealerCODECODCGB21
Collins Stewart Europe LimitedMarket Maker(MME)Broker/DealerCSCSCSTEGB21
Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Canaccord Genuity LimitedMarket Maker(MME)Broker/DealerCANAHOARGB21001
Liberum Capital LimitedMarket Maker(MME)Broker/DealerLIBCLCAPGB21
Panmure Gordon (UK) LimitedMarket Maker(MME)Broker/DealerPMURPMURGB2L
Shore Capital Stockbrokers LtdMarket Maker(MME)Broker/DealerSCAPSHOCGB21
Merrill Lynch InternationalMarket Maker(MME)Broker/DealerMLSBSNCSGB2LBIC
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V:gb D:20180123 22:10:59